[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 28, 2001

Underuse of β-Blockers Following Myocardial Infarction

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(8):1013. doi:10.1001/jama.285.8.1013

To the Editor: The article by Dr Phillips and colleagues,1 which estimated the cost-effectiveness of β-blocker therapy in all patients with myocardial infarction, adds to literature documenting poor health outcomes associated with underuse of β-blockers.2 Although we agree with the conclusions that increased β-blocker use would lead to impressive gains in health, we believe that the authors neglected to consider the costs of program implementation in their analysis.

First Page Preview View Large
First page PDF preview
First page PDF preview
×